Travis Gettys is a senior editor for Raw Story based in northern Kentucky. He previously worked as a web editor for WLWT-TV and a contributing writer for the Kentucky Enquirer, and he also wrote for ...

As the researchers behind Pfizer and Astellas' Padcev and Merck's Keytruda have taken victory laps on the heels of the positive readout of Keynote-905 study—also known as EV-303—terms like ...

Murugan Anandarajan does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

The one practical career security no one can take from you is control. I’ve built my career on five core mindsets that helped me transition to being responsible for my own career success. It’s how I ...

People are starting to “talk like AI,” according to OpenAI CEO Sam Altman. While teachers and business leaders complain about people using AI chatbots to write and communicate — and more and more ...

The debate about AI’s impact on consulting tends to swing between two extremes: Some argue that AI will render consultants obsolete; others claim it will only make them more indispensable. Both views ...

"…and my early concept sketch for the little guy, which was just a small Superman with two safety pins on his underwear. Thank Rao for Martín. See ya next month ...

Superman is one of the most powerful beings in the DC Multiverse, having started his journey nearly 90 years ago. The Man of Steel has remained an iconic superhero ever since, and numerous iterations ...

Most people are familiar with the concept of Kryptonite. The irradiated pieces of the planet Krypton are one of the few things capable of hurting Superman. Fewer people know, however, that there are ...

With a chemical formula nearly identical to fictional kryptonite, unique mineral jadarite has the potential to power a million electric vehicles each year. But it remains firmly underground, beneath a ...

The stock market's record highs are masking underlying economic weakness, driven largely by AI enthusiasm and the outperformance of the Magnificent 7 stocks. Hawkish Fed policy and escalating Trump ...

ATNM-400 demonstrated significant in vitro tumor cell killing when used in combination with AR-targeting agents, such as enzalutamide (Xtandi ®) The ATNM-400 enzalutamide combination produced superior ...